The benefits and risks of alemtuzumab in multiple sclerosis

被引：0
|
作者：
Ontaneda, Daniel [1 ]
Cohen, Jeffrey A. [1 ]
机构：
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Neurol Inst, Cleveland, OH 44106 USA
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2013年 / 9卷 / 03期
关键词：
alemtuzumab; efficacy; multiple sclerosis; risk; THERAPEUTIC LYMPHOCYTE DEPLETION; DISEASE;
D O I：
10.1586/ECI.13.1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：189 / 191
页数：3
相关论文
共 50 条
  • [21] Alemtuzumab as Treatment for Multiple Sclerosis
    Katsavos, Serafeim
    Coles, Alasdair
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (10):
  • [22] Alemtuzumab Therapy for Multiple Sclerosis
    Coles, Alasdair J.
    NEUROTHERAPEUTICS, 2013, 10 (01) : 29 - 33
  • [23] Subcutaneous alemtuzumab for multiple sclerosis
    Tur, Carmen
    Montalban, Xavier
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (05) : 423 - 426
  • [24] Mitoxantrone: benefits and risks in multiple sclerosis patients
    Martinelli, V.
    Radaelli, M.
    Straffi, L.
    Rodegher, M.
    Comi, G.
    NEUROLOGICAL SCIENCES, 2009, 30 : 167 - 170
  • [25] Mitoxantrone: benefits and risks in multiple sclerosis patients
    V. Martinelli
    M. Radaelli
    L. Straffi
    M. Rodegher
    G. Comi
    Neurological Sciences, 2009, 30 : 167 - 170
  • [26] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [27] FOLLOW UP EXAMINATION OF MULTIPLE SCLEROSIS PATIENTS TREATED WITH ALEMTUZUMAB IN MULTIPLE SCLEROSIS CENTRE, SZEGED
    Fricska-Nagy Zsanett
    Fuvesi Judit
    Kincses Zsigmond Tamas
    Legradi Dora
    Vecsei Laszlo
    Klivenyi Peter
    Bencsik Krisztina
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2022, 75 (11-12): : 377 - 384
  • [28] Alemtuzumab for multiple sclerosis
    Riera, Rachel
    Torloni, Maria Regina
    Martimbianco, Ana Luiza C.
    Pacheco, Rafael L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
  • [29] Alemtuzumab for multiple sclerosis
    Riera, Rachel
    Porfirio, Gustavo J. M.
    Torloni, Maria R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [30] The role of natalizumab in the treatment of multiple sclerosis: benefits and risks
    Singer, Barry A.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (09) : 327 - 336
12345